Sign in

CIK 0001711279

  • Large accelerated filer

Krystal Biotech, Inc.

Sign in to watch
Ticker
KRYS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
Operating
EIN
821080209
Phone
+1 412-586-5830
Business address
2100 WHARTON STREET, SUITE 701, PITTSBURGH, PA, 15203
  1. 4 Shares withheld for taxes President, R&D gave up 43,877 shares (to pay taxes)
  2. 4 Shares withheld for taxes President and CEO gave up 43,877 shares (to pay taxes)
  3. 4 Planned sale President, R&D sold 50,000 shares at an average $164.80 ($8,240,023)
  4. 4 Planned sale President and CEO sold 50,000 shares at an average $164.80 ($8,240,023)
  5. 4 Planned sale President, R&D sold 50,000 shares at an average $197.77 ($9,888,276)
  6. 4 Planned sale President and CEO sold 50,000 shares at an average $197.77 ($9,888,276)
  7. 4 Gift Director gave 5,000 shares (gift)
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Planned sale President, R&D sold 50,000 shares at an average $175.76 ($8,788,062)
  15. 4 Planned sale President and CEO sold 50,000 shares at an average $175.76 ($8,788,062)
  16. 4 Open-market sale Director sold 20,000 shares at an average $164.13 ($3,282,690)
  17. 4 Planned sale President, R&D sold 50,000 shares at an average $170.95 ($8,547,719)
  18. 4 Planned sale President and CEO sold 50,000 shares at an average $170.95 ($8,547,719)
  19. 4 Planned sale Chief Accounting Officer sold 5,000 shares at an average $165.88 ($829,417)
  20. 4 Planned sale Chief Accounting Officer sold 7,500 shares at an average $166.05 ($1,245,381)

Page 3 of 10 · 186 filings